Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Andrea Caia"'
Autor:
Klara Komici, Fabio D’Amico, Sofia Verderosa, Iacopo Piomboni, Carmine D’Addona, Vito Picerno, Antonio Bianco, Andrea Caiazzo, Leonardo Bencivenga, Giuseppe Rengo, Germano Guerra
Publikováno v:
Nutrients, Vol 14, Iss 18, p 3844 (2022)
Background: Given the potential risk of unhealthy weight management, the monitoring of body composition in athletes is advised. However, limited data reveal how body composition measurements can benefit athlete health and, in particular, respiratory
Externí odkaz:
https://doaj.org/article/85815853ee2e432b988926513f22c52c
Autor:
Krina Patel, Paula Rodríguez-Otero, Salomon Manier, Rachid Baz, Marc S. Raab, Michele Cavo, Natalie Callander, Luciano Costa, Philippe Moreau, Scott Solomon, Christine Chen, Noopur Raje, Christof Scheid, Michel Delforge, Jeremy Larsen, Thomas Pabst, Kenshi Suzuki, Anna Truppel-Hartmann, Zhihong Yang, Julia Piasecki, Jasper Felten, Andrea Caia, Mark Cook, Sergio Giralt, Maria-Victoria Mateos
Publikováno v:
HemaSphere, Vol 7, p e369897b (2023)
Externí odkaz:
https://doaj.org/article/4c0965e732c84effab073423b849e6b3
Autor:
Salomon Manier, Paula Rodríguez-Otero, Maria-Victoria Mateos, Hermann Einsele, Nizar J Bahlis, Nikhil Munshi, Sikander Ailawadhi, Bertrand Arnulf, Ajay Nooka, Ravi Vij, Ingerid Weum Abrahamsen, Annemiek Broijl, Sundar Jagannath, Reuben Benjamin, Usama Gergis, Douglas W. Sborov, Shinsuke Iida, Anna Truppel-Hartmann, Zhihong Yang, Julia Piasecki, Jasper Felten, Andrea Caia, Mark Cook, Rachid Baz
Publikováno v:
HemaSphere, Vol 7, p e3385948 (2023)
Externí odkaz:
https://doaj.org/article/5953e70c506043f1be82ad51da50daef
Autor:
Paula Rodriguez-Otero, Sagar Lonial, Sundar Jagannath, Damian J. Green, Nathan Martin, Maria-Victoria Mateos, Jesus G. Berdeja, Adrianna Gipson, Noopur Raje, Zhihong Yang, Andrea Caia, Gianfranco Pittari
Publikováno v:
Blood. 138:4830-4830
Background Patients (pts) with RRMM previously exposed to immunomodulatory agents, proteasome inhibitors (PIs), and anti-CD38 antibodies were reported to have poor outcomes with subsequent therapy, and deep and durable responses were uncommon (Chari
Autor:
Timothy B. Campbell, Jesus G. Berdeja, Fabio Petrocca, Jacalyn Rosenblatt, Deepu Madduri, Sundar Jagannath, Nikhil C. Munshi, David S. Siegel, Yi Lin, Andrea Caia, Noopur Raje, Marcela V. Maus, Michaela Liedtke, Kristen Hege, James N. Kochenderfer, Monica Massaro, Zhihong Yang
Publikováno v:
Blood. 136:26-27
Background: Ide-cel, a BCMA-directed CAR T cell therapy, showed tolerability and promising efficacy in patients with relapsed and/or refractory multiple myeloma (RRMM) in the first-in-human phase 1 CRB-401 study (Raje et al. N Engl J Med. 2019;380:17